Gabriel R. V.
- Country
- Spain
- Department
- Psiquiatria
Research Overview
- Phase II Randomized Placebo‑Controlled Trial of Oral Cannabidiol (600 mg) for Reducing Alcohol Consumption in Adults with Alcohol Dependence
- Phase II, Placebo-Controlled Study of Cannabidiol in the Management of Alcohol Dependence in Treatment-Seeking Patients
- Phase II, Placebo-controlled trial of Cannabidiol for the treatment of alcohol dependence (PLACONCANALDE)
Data & Insights
Has run more than one trial at 1 of 1 partner site.
Specializations
Addiction Medicine
The investigator specializes in studying innovative treatments for alcohol dependence, with particular emphasis on exploring alternative therapeutic approaches using cannabinoid-based interventions.
- Alcohol Use Disorder Treatment
- Addiction Recovery Mechanisms
- Therapeutic Applications of Cannabinoids
Clinical research focuses on evaluating biological markers and behavioral assessments in addiction treatment.
Substance Use Disorders
Investigates the effectiveness of novel therapeutic compounds in managing substance dependence, with specific attention to treatment-seeking populations and abstinence maintenance.
- Abstinence Support Strategies
- Biomarker Assessment
- Treatment Outcome Evaluation
Employs comprehensive assessment methods including behavioral tracking and biochemical markers.
Therapeutic Innovation
Explores the application of alternative pharmacological approaches in addiction medicine, focusing on the development of new treatment modalities for substance use disorders.
- Novel Treatment Development
- Clinical Assessment Methods
- Patient Recovery Monitoring
Integrates behavioral and biological measures to evaluate treatment effectiveness.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.